Marfan syndrome type II: There is more to marfan syndrome than fibrillin 1

Congenital Heart Disease

Volumn 1, Issue 5, 2006, Pages 229-232

  Zangwill, Steven D ^a   Brown, Matthew D ^a   Bryke, Christine R ^b   Cava, Joseph R ^a   Segura, Annette D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Comprehensive Genetic Services ^*  (United States)

Author keywords

Connective tissue Disorder; Loeys Dietz syndrome; Marfan syndrome type II; TGFBR1; TGFBR2

Indexed keywords

FIBRILLIN 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

AORTA ANEURYSM; AORTA ROOT; AORTA RUPTURE; ARTERY DILATATION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CARDIOVASCULAR DISEASE; CASE REPORT; CLEFT PALATE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTRACTURE; FACE DYSMORPHIA; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; MARFAN SYNDROME; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD;

AORTA; CHILD; CODON, NONSENSE; DILATATION, PATHOLOGIC; DNA MUTATIONAL ANALYSIS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MARFAN SYNDROME; MICROFILAMENT PROTEINS; MUTATION; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 33748532784     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2006.00040.x     Document Type: Article

References (14)

1. Pyeritz RE. The Marfan syndrome. Annu Rev Med. 2000; 51: 481-510.
2. Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005; 37: 275-281.
3. Collod G, Babron MC, Jondeau G, etal. A second focus for Marfan syndrome maps to chromosome 33/24.2-p25. Nat Genet. 1994; 8: 264-268.
4. Dietz HC, Cutting GR, Pyeritz RE, et al. Defects in the Fibrillin gene cause the Marfan syndrome; linkage evidence and identification of a missense mutation. Nature. 1991; 352: 337-339.
5. Ramirez F, Gayraud B, Pereira L. Marfan syndrome: New clues to genotype phenotype correlations. Annu Med. 1999; 31: 202-207.
6. Robinson PN, Godfrey M. The molecular genetics of Marfan syndrome and related microfibrillopathies in. J Med Genet. 2000; 37: 9-25.
7. Miziguschi T, Collod-Beroud GC, Akiyama T, etal. Heterozygous TGFBR2 mutations in Marfan Syndrome. Nat Genet. 2004; 36: 855-860.
8. Akhurst RJ. TGF-β signaling in health and disease. Nat Genet. 2004; 36: 790-792.
9. Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet. 2001; 29: 117-129.
10. Kaartiner V, Waburton D. Fibrillin controls TGF-β activation. Nat Genet. 2003; 33: 331-332.
11. Ramirez F, Sakai LY, Dietz HC, Rifkin DB. Fibrillin microfibrils: multipurpose extracellular networks in organismal physiology. Physiol Genomics. 2004; 19: 151-154.
12. Neptune ER, Frischmeyer PA, Arking DE, etal. Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome. Nat Genet. 2003; 33: 407-411.
13. Ng CM, Cheng A, Myers LA, et al. TGF-β-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest. 2004; 114: 1586-1592.
14. Disabella E, Grasso M, Marziliano N, etal. Two novel and one known mutation of the TGFBR2 gene in marfan syndrome not associated with F 137 BN1 gene defects. Eur J Hum Genet. 2006; 14: 34-38.